N-糖基酰胺的合成通常涉及使用糖基胺作为直接前体,由于水解和异构化过程导致立体控制的损失,导致产率低。在这项研究中,提出了使用糖基胺作为从糖基叠氮化物获得的中间体,连续合成N-糖基酰胺。合成了具有葡萄糖、半乳糖或木糖构型的衍生物。在立体控制下获得的己糖衍生物仅产生β端基异构体,而木糖衍生物则提供α和β端基异构体的混合物。构象分析表明,所有β端基异构体均采用4 C 1构象,而α端基异构体则以1 C 4构象为主要构象。脱-O-乙酰化后,含有半乳糖单元的衍生物被评估为大肠杆菌β-半乳糖苷酶抑制剂,结果发现是中等抑制剂。
Stereoselective Synthesis of α- and β-Glycosylamide Derivatives from Glycopyranosyl Azides via Isoxazoline Intermediates
摘要:
Treatment of 2-acetoxy glycopyranosyl azides with Ph3P gave isoxazolines by ring closure of the phosphorimine. Coupling of in situ generated isoxazolines with acylating reagents gave mixtures of alpha- or beta-glycopyranosyl amides. The alpha/beta ratio depended upon the acylating reagent and metal salts employed. For example, coupling of isoxazoline 3 with Z-Asp-(SPy)-OBn in the presence of CuCl2 gave exclusively alpha-N-glucopyranosylasparagine derivative 8. This general procedure has been applied to mono-, di-, and trisaccharide systems.
Synthesis of Glycosyl Amides Using Selenocarboxylates as Traceless Reagents for Amide Bond Formation
作者:Luana Silva、Ricardo F. Affeldt、Diogo S. Lüdtke
DOI:10.1021/acs.joc.6b00832
日期:2016.7.1
were successfully prepared in good yields from a broad range of substrates, including furanosyl and pyranosyl derivatives. The methodology successfully relied on the in situ generation of lithium selenocarboxylates from Se/LiEt3BH and acyl chlorides or carboxylic acids and their reaction with sugar azides. A key aspect of the present protocol is that we start from elemental selenium; isolation and handling
2,3,4,6-Tetra-O-acetyl-beta-D-glucopyranosyl- and 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-beta-D-glucopyranosyl azides were transformed into the corresponding per-O-acetylated N-(beta-D-glycopyranosyl) amides via a PMe3 mediated Staudinger protocol (generation of N-(beta-D-glycopyranosyl)imino-trimethylphosphoranes followed by acylation with carboxylic acids, acid chlorides or anhydrides). The deprotected compounds obtained by Zemplen deacetylation were evaluated as inhibitors of rabbit muscle glycogen phosphorylase b. The best inhibitor of this series has been N-(beta-D-glucopyranosyl) 3-(2-naphthyl)-propenoic amide (K-i = 3.5 muM). (C) 2004 Elsevier Ltd. All rights reserved.